Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
F11 antisense RNA 1 (F11-AS1) is a human long non-coding RNA gene located antisense to the F11 gene (which encodes coagulation factor XI). F11-AS1 belongs to the lncRNA gene class and functions as an antisense RNA, possibly modulating gene expression via epigenetic and transcriptional mechanisms. It has been implicated through genomic and expression studies in various cancers, including as a potential biomarker for disease status and prognosis (especially in liver cancer and glioma susceptibility). There is no current evidence that it interacts directly with drugs or serves as a validated receptor, enzyme, or transporter therapeutic target[6][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F11 antisense RNA 1 (F11-AS1).